BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 965902)

  • 1. Critical evaluation of measurement of platelet monoamine oxidase in man.
    Honecker H; Christ W; Müller-Oerlinghausen B; Coper H
    J Clin Chem Clin Biochem; 1976 Sep; 14(9):453-8. PubMed ID: 965902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.
    Demisch L; von der Mühlen H; Bochnik HJ; Seiler N
    Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes.
    Bond PA; Cundall RL
    Clin Chim Acta; 1977 Oct; 80(2):317-26. PubMed ID: 912905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
    Dyck LE; Boulton AA
    Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
    Dyck LE
    Life Sci; 1989; 44(17):1149-56. PubMed ID: 2716465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 9. Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
    Reynolds GP; Riederer P
    Int Pharmacopsychiatry; 1981; 16(1):30-3. PubMed ID: 7298269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some properties of human platelet monoamine oxidase in iron-deficiency anaemia.
    Youdim MB; Grahame-Smith DG; Woods HF
    Clin Sci Mol Med; 1976 Jun; 50(6):479-85. PubMed ID: 6185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic effects of tranylcypromine vs. amitriptyline.
    White K; O'Leary J; Razani J; Rebal R; Palmer R
    J Clin Psychiatry; 1983 Mar; 44(3):91-3. PubMed ID: 6833194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.
    Elsworth JD; Glover V; Reynolds GP; Sandler M; Lees AJ; Phuapradit P; Shaw KM; Stern GM; Kumar P
    Psychopharmacology (Berl); 1978 Apr; 57(1):33-8. PubMed ID: 96466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and monoamine oxidase.
    Coper H; Fähndrich E; Gebert A; Helmchen H; Honecker H; Müller-Oerlinghausen B; Pietzcker A
    Prog Neuropsychopharmacol; 1979; 3(5-6):441-63. PubMed ID: 401000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteers.
    Bieck PR; Antonin KH
    Eur J Clin Pharmacol; 1982; 22(4):301-8. PubMed ID: 7106165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 18. Twin studies and substrate differences in platelet monoamine oxidase activity.
    Hussein L; Sindarto E; Goedde HW
    Hum Hered; 1980; 30(2):65-70. PubMed ID: 7188930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
    Sullivan JL; Dackis C; Stanfield C
    Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors altering platelet monoamine oxidase. The influence of oral glucose intake.
    Demisch L; Demisch K; Seiler N
    Metabolism; 1979 Feb; 28(2):144-50. PubMed ID: 763148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.